YU46699A - Poboljšan postupak za dobivanje tiazolidindiona i novi tiazolidindioni - Google Patents

Poboljšan postupak za dobivanje tiazolidindiona i novi tiazolidindioni

Info

Publication number
YU46699A
YU46699A YU46699A YU46699A YU46699A YU 46699 A YU46699 A YU 46699A YU 46699 A YU46699 A YU 46699A YU 46699 A YU46699 A YU 46699A YU 46699 A YU46699 A YU 46699A
Authority
YU
Yugoslavia
Prior art keywords
thiazolidinediones
improved method
producing
compounds
new
Prior art date
Application number
YU46699A
Other languages
English (en)
Inventor
Hans-Peter Wolff
Ernst-Christian Witte
Hans-Frieder Kuhnle
Original Assignee
Roche Diagnostics Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh. filed Critical Roche Diagnostics Gmbh.
Publication of YU46699A publication Critical patent/YU46699A/sh
Publication of RS49771B publication Critical patent/RS49771B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Ovaj pronalazak se odnosi na poboljšan postupak za dobivanje jedinjenja formule (III) u kojoj označavaju A CH=CH ili S, W O, X S, O ili NR2, pri čemu ostatak R2 označava vodonik ii C1-C6-alkil,-X CH ili N, R naftil, tienil ili fenil, koji je u datom slučaju mono- ili disupstituisan C1-C3-alkilom, CF3, C1-C3-alkoksi, F, CI ili bromom, R1 vodonik ili C1-C6-alkil i n 1-3, naznačen time, što se jedinjenje formule IV u kojoj A, W, X, Y, R, R1 i n imaju gore dato značenje, reaguje sa aktiviranim aluminijumom u protičnom rastvaraču. Ovaj pronalazak se takodje odnosi na nova jedinjenja formule III i na lekove koji sadrže ova jedinjenja[The invention relates to an improved method for producing compounds of the formula (III) wherein A represents CH=CH or S, W represents O, X represents S, O or NR2, the radical R2 being hydrogen or C1-C6alkyl, Y represents CH or N, R represents naphthyl, thienyl or phenyl which is optionally mono- or disubstituted with C1-C3 alkyl, CF3, C1-C3 alkoxy, F, CI or bromine, R1 represents hydrogen or C1-C6 alkyl and n represents 1-3 by reacting compounds of the formula (IV) wherein A, W, X, Y, R, R1 and n have the meaning given above with activated aluminum in a protic solvent. The invention also relates to new compounds of the formula III and medicaments containing these compounds.
YUP-466/99A 1997-03-20 1998-03-17 Postupak za dobivanje tiazolidindiona i novi tiazolidindioni RS49771B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19711616A DE19711616A1 (de) 1997-03-20 1997-03-20 Verbessertes Verfahren zur Herstellung von Thiazolidindionen

Publications (2)

Publication Number Publication Date
YU46699A true YU46699A (sh) 2002-06-19
RS49771B RS49771B (sr) 2008-06-05

Family

ID=7824011

Country Status (26)

Country Link
US (2) US6258832B1 (sh)
EP (1) EP0970077B1 (sh)
JP (2) JP3484200B2 (sh)
KR (1) KR100340353B1 (sh)
CN (1) CN1105718C (sh)
AR (1) AR012124A1 (sh)
AT (1) ATE240324T1 (sh)
AU (1) AU726048B2 (sh)
BR (1) BR9808029A (sh)
CA (1) CA2285208C (sh)
DE (2) DE19711616A1 (sh)
DK (1) DK0970077T3 (sh)
ES (1) ES2198053T3 (sh)
HK (1) HK1025965A1 (sh)
HU (1) HUP0001551A3 (sh)
IL (1) IL131772A (sh)
NO (1) NO313292B1 (sh)
NZ (1) NZ337608A (sh)
PL (1) PL192201B1 (sh)
PT (1) PT970077E (sh)
RS (1) RS49771B (sh)
RU (1) RU2181724C2 (sh)
TR (1) TR199902197T2 (sh)
TW (1) TW487707B (sh)
WO (1) WO1998042704A1 (sh)
ZA (1) ZA982326B (sh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1078923E (pt) 1999-08-02 2006-07-31 Hoffmann La Roche Processo para a preparacao de derivados de benzotiofeno
US6531609B2 (en) * 2000-04-14 2003-03-11 Hoffmann-La Roche Inc. Process for the preparation of thiazolidinedione derivatives
FR2820742B1 (fr) * 2001-02-14 2005-03-11 Ppg Sipsy Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
FR2820741A1 (fr) * 2001-02-14 2002-08-16 Ppg Sipsy Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
US7323481B2 (en) 2001-04-06 2008-01-29 Hoffmann-La Roche Inc. Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth
RU2278859C2 (ru) * 2001-05-15 2006-06-27 Ф.Хоффманн-Ля Рош Аг Замещенные карбоновыми кислотами оксазоловые производные в качестве ppar-альфа и гамма-активаторов при лечении диабета
ES2291688T3 (es) * 2002-07-03 2008-03-01 F. Hoffmann-La Roche Ag Derivados de oxazol y su empleo como sensibilizadores a la insulina.
RU2296754C2 (ru) * 2002-08-30 2007-04-10 Ф.Хоффманн-Ля Рош Аг НОВЫЕ СОЕДИНЕНИЯ 2-АРИЛТИАЗОЛА В КАЧЕСТВЕ АГОНИСТОВ PPAR α И PPAR γ
BR0314261A (pt) * 2002-09-12 2005-07-26 Hoffmann La Roche Compostos, processo de preparação de um composto, composição farmacêutica que compreende o mesmo, utilização de um composto, método para tratamento e/ou profilaxia de enfermidades e utilização e/ou método de tratamento
JP4384052B2 (ja) * 2002-11-25 2009-12-16 エフ.ホフマン−ラ ロシュ アーゲー インドリル誘導体
CA2530309A1 (en) * 2003-06-26 2005-01-06 F. Hoffmann-La Roche Ag Process for the preparation of insulin sensitizer and intermediate compound thereof
US20210172624A1 (en) 2019-12-10 2021-06-10 Lg Electronics Inc. Air management apparatus or device

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003445B (zh) 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
US4703052A (en) 1985-05-21 1987-10-27 Pfizer Inc. Hypoglycemic thiazolidinediones
GB8713861D0 (en) 1987-06-13 1987-07-15 Beecham Group Plc Compounds
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
US5330998A (en) 1988-03-08 1994-07-19 Pfizer Inc. Thiazolidinedione derivatives as hypoglycemic agents
MX15171A (es) 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
US5061717A (en) 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
HU217432B (hu) 1988-03-08 2000-01-28 Pfizer Inc. Eljárás tiazolidin-dion-származékok és az ezeket tartalmazó gyógyszerkészítmények előállítására, a vegyületek és a készítmények
ATE205206T1 (de) * 1990-04-27 2001-09-15 Sankyo Co Benzylidenthiazolidinderivate, ihre herstellung und ihre anwendung als lipidperoxid-inhibitoren
JPH0678326B2 (ja) 1990-08-23 1994-10-05 フアイザー・インコーポレイテツド 血糖低下性ヒドロキシ尿素誘導体
WO1993013095A1 (en) 1991-12-20 1993-07-08 The Upjohn Company A reduction method for substituted 5-methylene-thiazolidinediones
FR2688220A1 (fr) 1992-03-06 1993-09-10 Adir Nouveaux derives de thiazolidine-2,4-dione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE4317320A1 (de) * 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
DK0684242T3 (da) 1993-12-27 1999-11-01 Japan Tobacco Inc Isoxazolidindionderivat og anvendelse deraf

Also Published As

Publication number Publication date
TR199902197T2 (xx) 1999-12-21
HUP0001551A3 (en) 2000-12-28
NO994505L (no) 1999-11-17
IL131772A (en) 2002-09-12
IL131772A0 (en) 2001-03-19
RS49771B (sr) 2008-06-05
CN1250448A (zh) 2000-04-12
CA2285208C (en) 2003-07-08
PL192201B1 (pl) 2006-09-29
CA2285208A1 (en) 1998-10-01
BR9808029A (pt) 2000-03-08
NO994505D0 (no) 1999-09-17
DE19711616A1 (de) 1998-09-24
HUP0001551A2 (hu) 2000-11-28
ATE240324T1 (de) 2003-05-15
ZA982326B (en) 1999-09-20
RU2181724C2 (ru) 2002-04-27
NZ337608A (en) 2001-05-25
AR012124A1 (es) 2000-09-27
US20010008902A1 (en) 2001-07-19
CN1105718C (zh) 2003-04-16
JP2004067697A (ja) 2004-03-04
PL335903A1 (en) 2000-05-22
JP2000512312A (ja) 2000-09-19
TW487707B (en) 2002-05-21
US6258832B1 (en) 2001-07-10
JP3484200B2 (ja) 2004-01-06
AU7036198A (en) 1998-10-20
ES2198053T3 (es) 2004-01-16
EP0970077A1 (de) 2000-01-12
AU726048B2 (en) 2000-10-26
WO1998042704A1 (de) 1998-10-01
HK1025965A1 (en) 2000-12-01
US6441185B2 (en) 2002-08-27
KR100340353B1 (ko) 2002-06-12
DE59808365D1 (de) 2003-06-18
KR20000076344A (ko) 2000-12-26
PT970077E (pt) 2003-08-29
NO313292B1 (no) 2002-09-09
EP0970077B1 (de) 2003-05-14
DK0970077T3 (da) 2003-09-01

Similar Documents

Publication Publication Date Title
RU2123493C1 (ru) Способ получения сложных эфиров баккатина-iii и 10-дезацетил-баккатина-iii, активированные кислоты и их производные
YU46699A (sh) Poboljšan postupak za dobivanje tiazolidindiona i novi tiazolidindioni
RU98119523A (ru) Соединения пиперазина и пиперидина
UA37202C2 (uk) Карбамати, проміжні сполуки, фунгіцидна композиція, спосіб боротьби з грибами
MY141468A (en) 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
NO990583L (no) Cykliske eterforbindelser som natriumkanalmodulatorer
MX9804105A (es) Antagonistas de taquicininas a base de piperidonas.
IL160304A (en) Compounds and composition for activating peroxisome proliferators-responsive receptor ??
ID17851A (id) Persenyawaan heterosiklis, produksi dan pemakaiannya
GB0129476D0 (en) Organic compounds
HUT74182A (en) Novel imidazole derivatives, process for producing the same and pharmaceutical compositions containing the compounds
BG104287A (en) Halogensubstituted tetracyclic derivatives of tetrahydrofuran
NZ504024A (en) Quinoline- or quinazoline-containing alpha-ketoamide cysteine and serine protease inhibitors
EP0602254A4 (en) POLYMERIZABLE MONOMER AND ITS POLYMER; ASSOCIATED PRODUCTION PROCESS.
ATE285238T1 (de) Verfahren zur senkung des serumcholesterinspiegels mit 2,6-dialkyl-4 silyl- phenol derivaten
DK0533504T3 (da) Dihydropyridinderivater, der er nyttige ved antitumorterapi
UA39935C2 (uk) Спосіб алкоксиметилювання 1н-пірольних сполук
ATE328858T1 (de) Verfahren zur alkoxylierung mit einem bor- enthaltenden katalysator
FI901659A0 (fi) 3,5-dihydroxi-6,8-nonadiensyror och derivat som kolesterol saenkande aemnen.
WO1998053790A3 (en) Compounds that inhibit the binding of vascular endothelial growth factor to its receptors
TW200621894A (en) Room temperature curing organic polysiloxane composition
ATE234826T1 (de) Verfahren zur lagerstabilisierung von verbindungen mit oxetan ringen
JPS646263A (en) Novel thiazolidine derivative, its production and antiamnestic agent containing same
ES2186232T3 (es) Procedimiento de sintesis de pirrol amidas.
EP0516860A4 (en) Chromone derivative and aldose reductase inhibitor containing the same as active ingredient